The present invention relates to methods for the treatment of inflammation
and pain without increasing cardiovascular risk by administration of an
inhibitor of mPGES-1. The invention further is related to identifying
inhibitors of mPGES-1 that do not increase cardiovascular risk when
administered to an individual.